| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| CervoMed Inc. | SVP, Clinical Development | Stock Option (Right to Buy) | 27,000 | 04 Feb 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| CRVO | CervoMed Inc. | 04 Feb 2025 | 1 | $0 | 4 | SVP, Clinical Development | 14 Feb 2025, 18:00 |
| CRVO | CervoMed Inc. | 26 Jan 2024 | 1 | $0 | 4 | SVP, Clinical Development | 26 Jan 2024, 18:46 |
| CRVO | CervoMed Inc. | 15 Sep 2023 | 1 | $0 | 4 | VP, Clinical Development | 15 Sep 2023, 19:49 |
| CRVO | CervoMed Inc. | 16 Aug 2023 | 0 | $0 | 3 | VP, Clinical Development | 23 Aug 2023, 22:52 |